TXMD שיעור רווח גולמי TherapeuticsMD Corp

Stabilization of licensing payments and balance sheet optimization at TherapeuticsMD, Inc. (TXMD) support cash flows, which is confirmed by the gross profit margin. The value 49.40 indicates the current profitability level. However, the transition to a passive royalty model and the loss of market share to tech giants create a dependency on partners, while a high debt load combined with the threat of delisting limits the company's growth potential.
פילוחי מדדים מקיפים ואנליטיקה עבור TherapeuticsMD (TXMD)

Gross margin is calculated as the ratio of the difference between total income and direct production costs to total revenue, measuring the efficiency of cost-of-goods-sold management. The optimization of laboratory waste and energy consumption within the ESG strategy of TherapeuticsMD, Inc. (TXMD) directly reduces expenses, which is reflected in the gross profit margin on the GURU.Markets platform as an indicator of the business's operational resilience.